PZL · Class II · 21 CFR 878.4685

FDA Product Code PZL: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers

Treatment Of Diabetic Foot Ulcers

Leading manufacturers include Softwave/Trt, LLC, E.M.S Electro Medical Systems S.A and Curative Sound Therapeutics.

8
Total
7
Cleared
212d
Avg days
2017
Since
Growing category - 3 submissions in the last 2 years vs 1 in the prior period
Consistent review times: 206d avg (recent)

FDA 510(k) Cleared Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers Devices (Product Code PZL)

8 devices
1–8 of 8

About Product Code PZL - Regulatory Context

510(k) Submission Activity

8 total 510(k) submissions under product code PZL since 2017, with 7 receiving FDA clearance (average review time: 212 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

FDA review times for PZL submissions have been consistent, averaging 206 days recently vs 215 days historically.

PZL devices are reviewed by the General & Plastic Surgery panel. Browse all General & Plastic Surgery devices →